Chemical-structures (Imcivree 01)
Imcivree Solution
Product Images NDC 72829-010
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Imcivree (NDC 72829-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rhythm Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Imcivree 02)
This appears to be a table or graph showing the percentage change in body weight for two studies (one related to genes POMC or PCSK1, and the other related to gene LEPR) with a comparison between placebo and a medication that includes withdraml. There are also different periods, possibly baseline and final, and a series of visit designations. However, without additional context or information, the data is not especially useful or informative.*
Figure A (Imcivree 03)
This is a table that shows the prescribed dose (in mg) and the corresponding prescribed dose (in mL) for a 10 mg/ 1 mL multiple-dose vial. The table also provides the number of doses per vial for different dose measurements, including 0.5mg, 1mg, 15mg, 2mg, and 3mg.*
Figure B (Imcivree 04)
This text provides a list of supplies needed to perform a medical procedure that involves the use of a syringe, needle, and other materials. The supplies include a plastic cap, rubber stopper, vial, alcohol wipes, plunger, one mL syringe with a 28-29 gauge needle, gauze pad, and a sharps container. The information is accompanied by a labelled diagram of the various components.*
Figure C (Imcivree 05)
Figure D (Imcivree 06)
Figure E (Imcivree 07)
Figure F (Imcivree 08)
Figure G (Imcivree 09)
This text is providing a conversion factor between a 0.5 mg dose and a volume of 0.05 mL.*
Figure H (Imcivree 10)
Figure I (Imcivree 11)
Figure J (Imcivree 12)
Figure K (Imcivree 13)
Figure L (Imcivree 14)
Figure M (Imcivree 15)
Figure N (Imcivree 16)
Figure O (Imcivree 17)
Figure P (Imcivree 18)
Figure Q (Imcivree 19)
Figure R (Imcivree 20)
Figure S (Imcivree 21)
Carton Label (Imcivree 22)
IMCIVREE is a prescription medication used for subcutaneous injection. It comes in a one mL multiple-dose vial for single-patient-use. It contains Setmelanotide, MPEG-2000-DSPE, Mannitol, Carboxymethylcellulose Sodium, Phenol, Benzyl Alcohol, and Edetate Disodium dihydrate. The dosage and administration needed will require a prescription, and its details can be found in the prescribing information. IMCIVREE should be stored in the refrigerator at a temperature of 2°C to 8°C if the vial is unopened. Opened vials can be stored at a temperature of 2°C to 25°C with excursions permitted up to 30°C. Any unused portion of the medication must be discarded after 30 days of first opening or if stored above 30°C. It's manufactured for Rhythm Pharmaceuticals, Inc., and is a product of France.*
Vial Label (Imcivree 23)
This is a description for IMCIVREE, a drug with the National Drug Code (NDC) 72829-010-01, which is intended only for subcutaneous (under the skin) use. The drug is administered through injection and is manufactured by Rhythm Pharmaceuticals, Inc. based in Boston, MA.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
